| Net revenue | 91.84M |
| Personnel expense | 31.51M |
| Medical supplies expense | 24.22M |
| Bad debt expense | 10.77M |
| Other operating expenses | 23.92M |
| Pre-opening expenses | 0 |
| Depreciation | 3.75M |
| Impairment of property and equipment | 810K |
| (Gain) loss on disposal of property, equipment and other assets | -212K |
| Total operating expenses | 94.76M |
| Loss from operations | -2.92M |
| Interest expense | -556K |
| Interest and other income | 76K |
| Loss on note receivable | 0 |
| Gain on sale of unconsolidated affiliates | 0 |
| Equity in net earnings of unconsolidated affiliates | 303K |
| Total other income (expense), net | -177K |
| Loss from continuing operations before income taxes | -3.1M |
| Income tax benefit | -1.86M |
| Loss from continuing operations | -1.24M |
| Income from discontinued operations, net of taxes | 15.26M |
| Net income (loss) | 14.02M |
| Less: Net income attributable to noncontrolling interest | -1.69M |
| Net income (loss) attributable to MedCath Corporation | 12.33M |
| Loss from continuing operations, net of taxes | -3.09M |
| Income from discontinued operations, net of taxes | 15.42M |
| Net income (loss) | 12.33M |
| (Loss) earnings per share, basic | |
| Loss from continuing operations attributable to MedCath Corporation common stockholders | -0.15 |
| Income from discontinued operations attributable to MedCath Corporation common stockholders | 0.76 |
| (Loss) earnings per share, basic | 0.61 |
| (Loss) earnings per share, diluted | |
| Loss from continuing operations attributable to MedCath Corporation common stockholders | -0.15 |
| Income from discontinued operations attributable to MedCath Corporation common stockholders | 0.76 |
| (Loss) earnings per share, diluted | 0.61 |
| Weighted average number of shares, basic | 20.25K |
| Dilutive effect of stock options and restricted stock | 7 |
| Weighted average number of shares, diluted | 20.25K |